المؤلفون: Borysiewicz LK; Department of Medicine, University of Wales College of Medicine, Cardiff, UK., Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, Evans AS, Adams M, Stacey SN, Boursnell ME, Rutherford E, Hickling JK, Inglis SC

المصدر: Lancet (London, England) [Lancet] 1996 Jun 01; Vol. 347 (9014), pp. 1523-7.

نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print ISSN: 0140-6736 (Print) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Oncogene Proteins, Viral*/*therapeutic use, DNA-Binding Proteins* , Immunotherapy, Active* , Papillomaviridae* , Repressor Proteins* , Vaccinia virus*, Uterine Cervical Neoplasms/*therapy , Vaccines, Synthetic/*therapeutic use, Adult ; Aged ; Antibodies, Viral/immunology ; Female ; Humans ; Middle Aged ; Papillomavirus E7 Proteins ; Papillomavirus Vaccines ; T-Lymphocytes, Cytotoxic/immunology ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/virology ; Viral Vaccines